Headache Disorder — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for headache disorder. 27 active patents protecting 3 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

3
Approved drugs
27
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in Headache Disorder

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Boots Group) 17 patents Baxter 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating headache disorder. Each bar = one year. Y-axis scaled to peak year (8 patents).

2
28
8
29
2
30
4
32
4
33
3
34
3
35
1
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Advil
ibuprofen
 Generic (originally Boots Group) 14 70 — 2029-09-30
Renacidin
CITRIC ACID
 Baxter 10 56 — 2028-10-10
Mucinex
guaifenesin
 Generic (multiple manufacturers) 3 62 — 2035-11-13

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11806400 Advil method of use 76 2032-03-16
11806400 Advil method of use 76 2032-03-16
11992472 Renacidin method of use 75 2033-03-15
8735452 Advil method of use 73 2029-09-30
8871810 Advil method of use 73 2029-09-30
11337989 Renacidin method of use 70 2033-03-15
8735452 Advil method of use 68 2029-09-30
9138404 Advil method of use 68 2029-09-30
9114068 Advil method of use 68 2029-09-30
9649284 Advil method of use 68 2029-09-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11439610 Renacidin composition of matter 12 2033-03-15
10624879 Renacidin formulation 42 2034-06-23
12458634 Renacidin formulation 55 2038-01-27
8481083 Renacidin formulation 60 2028-10-10
8450338 Renacidin formulation 60 2028-10-10
10105324 Mucinex method of use 62 2035-11-13
9549907 Mucinex method of use 62 2035-11-13
9808431 Mucinex method of use 62 2035-11-13
9827231 Renacidin method of use 62 2034-06-26
11191753 Renacidin method of use 62 2034-06-23

Related